LicianPro

4D Molecular Therapeutics, Inc. ·

FDMT 8-K 2026-09-28

4D Molecular Therapeutics, Inc. (FDMT) 8-K dated 2026-09-28 — accession 0001193125-26-403424.

4D Molecular Therapeutics, Inc. (FDMT) is a biotechnology company listed on US.

4D Molecular Therapeutics, Inc. filed a 8-K on 2026-09-28. Accession 0001193125-26-403424.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported FDMT revenue for 2025-12-31 was $85.2M. Net income was -$140.1M. Revenue was up 230194.6% from 2024-12-31 to 2025-12-31. FDMT currently screens at market cap $518.1M.

Not investment advice. The FDMT SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr